Contemporary management of ventricular electrical storm in Europe: results of a European Heart Rhythm Association Survey.
Arrhythmic storm
Autonomic modulation
Catheter ablation
EHRA survey
Electrical storm
Ventricular arrhythmias
Journal
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
ISSN: 1532-2092
Titre abrégé: Europace
Pays: England
ID NLM: 100883649
Informations de publication
Date de publication:
15 04 2023
15 04 2023
Historique:
received:
04
08
2022
accepted:
04
08
2022
medline:
18
4
2023
pubmed:
6
10
2022
entrez:
5
10
2022
Statut:
ppublish
Résumé
Electrical storm (ES) is a predictor of mortality, and its treatment is challenging. Moreover, not all potential therapeutic strategies are available in all hospitals, and a standardized approach among European centres is lacking. The aim of this European Heart Rhythm Association (EHRA) survey was to assess the current management of patients with ES both in the acute and post-acute phases in 102 different European centres. A 20-item online questionnaire was sent out to the EHRA Research Network Centres. The median number of patients with ES treated annually per centre is 10 (IQR 5-15). The possibility of using autonomic modulation (e.g. percutaneous stellate ganglion block or thoracic epidural anaesthesia) for the acute ES treatment is available in only 29.3% of the centres. Moreover, although over 80% of centres perform ventricular tachycardia ablation, this procedure is available 24/7 in only 16.5% of the hospitals. There is a significant heterogeneity among centres regarding the availability of AADs and their use before deciding to proceed with a non-AAD strategy; specifically, 4.4% of centres use only one drug, 33.3% use two drugs, and 12.2% >two drugs, while about 50% of the centres decide based on individual patient's characteristics. Regarding the type of AADs used for the acute and post-acute management of ES patients, important variability is reported depending upon the underlying heart disease. Most patients considered for percutaneous ablation have structural heart disease. Only 46% of centres refer patients to psychological counselling after ES.
Identifiants
pubmed: 36196613
pii: 6748482
doi: 10.1093/europace/euac151
pmc: PMC10105853
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1277-1283Informations de copyright
© The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology.
Déclaration de conflit d'intérêts
Conflict of interest: M.M.F. received speaker and proctoring fees from Medtronic Poland and Abbott Poland. The other authors report no conflicts of interest related specifically to this manuscript.
Références
Europace. 2020 Jan 1;22(1):148
pubmed: 31257420
Pacing Clin Electrophysiol. 1983 Sep;6(5 Pt 2):1210-20
pubmed: 6195641
Acta Pharmacol Sin. 2011 Jun;32(6):817-23
pubmed: 21642950
Europace. 2014 Mar;16(3):347-53
pubmed: 24096960
Crit Care Med. 2020 Oct;48(10):e856-e863
pubmed: 32796185
Circulation. 2008 Jan 29;117(4):462-9
pubmed: 18172038
Europace. 2015 Nov;17(11):1601-87
pubmed: 26318695
J Am Heart Assoc. 2021 Jan 19;10(2):e018371
pubmed: 33441022
Eur J Heart Fail. 2021 Jan;23(1):195-196
pubmed: 33179329
Can J Cardiol. 2022 Apr;38(4):439-453
pubmed: 34979281
N Engl J Med. 2008 Sep 4;359(10):1009-17
pubmed: 18768944
J Am Heart Assoc. 2017 Oct 27;6(11):
pubmed: 29079570
Heart Rhythm. 2018 Jan;15(1):48-55
pubmed: 28843418
Circulation. 2001 Apr 24;103(16):2066-71
pubmed: 11319196
J Am Coll Cardiol. 1998 Dec;32(7):1909-15
pubmed: 9857871
Europace. 2014 Jan;16(1):92-100
pubmed: 23858022
J Am Coll Cardiol. 1996 Jan;27(1):67-75
pubmed: 8522712
Circ Arrhythm Electrophysiol. 2011 Apr;4(2):242-50
pubmed: 21505176
Basic Res Cardiol. 2013 Mar;108(2):336
pubmed: 23429935
Am Heart J. 1976 Nov;92(5):589-99
pubmed: 983934
Europace. 2021 Apr 6;23(4):581-586
pubmed: 33190159
Circulation. 1988 Jul;78(1):178-85
pubmed: 3383403
Europace. 2020 Dec 23;22(12):1768-1780
pubmed: 32984880
Eur Heart J. 2006 Dec;27(24):3027-32
pubmed: 17050586
World J Cardiol. 2017 Jun 26;9(6):521-530
pubmed: 28706587
N Engl J Med. 2017 Dec 14;377(24):2325-2336
pubmed: 29236642
Europace. 2020 Apr 1;22(4):606
pubmed: 32034906
JACC Clin Electrophysiol. 2020 May;6(5):562-571
pubmed: 32439042
Europace. 2000 Jul;2(3):263-9
pubmed: 11227599
J Interv Card Electrophysiol. 2017 Jan;48(1):27-34
pubmed: 27497847
Circulation. 2016 Feb 16;133(7):672-6
pubmed: 26884622
Europace. 2022 Oct 13;24(9):1504-1511
pubmed: 35851797
Can J Anaesth. 2002 Nov;49(9):973-7
pubmed: 12419728
Europace. 2019 Aug 1;21(8):1143-1144
pubmed: 31075787
Am J Physiol Heart Circ Physiol. 2017 Mar 1;312(3):H608-H621
pubmed: 28087519
JACC Clin Electrophysiol. 2017 Sep;3(9):942-949
pubmed: 29270467
Circulation. 2019 Jan 15;139(3):313-321
pubmed: 30586734
Circ Arrhythm Electrophysiol. 2019 Sep;12(9):e007118
pubmed: 31514529
J Am Coll Cardiol. 2018 May 1;71(17):1897-1906
pubmed: 29699616